title: Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
authors.forename: J H
authors.initials: JH
authors.lastname: Scarffe
authors.forename: J
authors.initials: J
authors.lastname: Wagstaff
authors.forename: D
authors.initials: D
authors.lastname: Crowther
mesh_terms: D002699:Chlorambucil / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins; D002699:Chlorambucil